SG3 Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 543 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 823 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 742 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 724 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 782 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 839 |
|
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$146K | – | 686 |
|
|
2020
Q3 | $146K | Buy |
+1,500
| New | +$146K | 0.01% | 188 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 426 |
|
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$818K | – | 289 |
|
|
2019
Q4 | $818K | Buy |
4,000
+2,500
| +167% | +$511K | 0.05% | 27 |
|
|
2019
Q3 | $120K | Hold |
1,500
| – | – | 0.01% | 59 |
|
|
2019
Q2 | $142K | Hold |
1,500
| – | – | 0.02% | 61 |
|
|
2019
Q1 | $128K | Buy |
+1,500
| New | +$128K | 0.01% | 49 |
|